Moreover, a class I HDAC inhibitor, MS-275, and a pan HDAC inhibitor, Suberoylanilide Hydroxamic Acid, attenuated the inflammatory response in LPS-induced human RA synovial fibroblastic E11 cells (67). This evidence concerns the gene HDAC9 and rheumatoid arthritis.